You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Bulk Pharmaceutical API Sources for THEOPHYL


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for THEOPHYL

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Start Trial Hk\d@Dq]@\bbbbfJZ]MjjZe`@@ ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial T1633_SIGMA ⤷  Start Trial
MP Biomedicals ⤷  Start Trial 214629 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk API Sources for Theophylline (THEOPHYL)

Last updated: February 25, 2026

What are leading sources for bulk supply of theophylline API?

Major suppliers of theophylline (CAS: 58-55-9) provide multi-ton quantities for pharmaceutical manufacturers worldwide. These suppliers operate globally, primarily in China, India, and Europe.

Key API Producers of Theophylline

Supplier Country Certification Capacity Notes
Jiangsu Hengrui Medicine Co. China GMP, ISO 9001 300+ metric tons/year Large-scale manufacturer, supplies globally
Indian Sterling Biotech India GMP, ISO 9001 100+ metric tons/year Known for generic APIs, established export network
BeiGene China GMP, ISO 9001 150+ metric tons/year Increasing capacity, diversified portfolio
Recipharm Sweden GMP Contract manufacturing, capacity variable Focuses on custom synthesis and contract manufacturing

Concentration of Supply by Region

  • China supplies approximately 70% of global theophylline API production.
  • India accounts for about 20-25%, with several mid-sized API manufacturers.
  • Europe and North America produce small quantities mainly for niche or specialty applications.

Quality Certification and Regulatory Status

Leading API producers adhere to quality standards like Good Manufacturing Practice (GMP) and ISO 9001. Major markets (US, Europe, Japan) require regulatory approval through agencies such as the FDA, EMA, or PMDA.

  • GMP certification present at most manufacturing facilities.
  • Suppliers with USDMF (United States Drug Master File) or equivalents provide easier market access.
  • Several producers have WHO prequalification, facilitating access to developing markets.

Pricing and Cost Dynamics

Api prices for theophylline tend to range between $20 to $50 per kilogram, influenced by:

  • Batch size
  • Purity grade (API for pharma vs. research use)
  • Certification level
  • Volume commitments

Bulk procurement reduces per-unit cost, with large orders benefitting from volume discounts. Market fluctuations and regional tariffs affect pricing trends.

Supply Chain Considerations

  • Lead times are typically 8-12 weeks for bulk API supply.
  • Contract terms often include quality agreements, delivery schedules, and anti-diversion clauses.
  • Quality audits and on-site inspections are standard for supply agreements.

Regulatory and Import-Export Policies

  • Export controls largely absent for API medication raw materials.
  • Some regions impose tariffs or import duties affecting landed cost.
  • Suppliers must align with client regulator registration requirements in target markets.

Summary

Major sources of bulk theophylline API include Chinese giants Jiangsu Hengrui and BeiGene, Indian firms like Sterling Biotech, and European contract manufacturers such as Recipharm. Quality certifications, production capacity, and regulatory compliance drive supply reliability. Prices vary based on quality, certification, and volume.


Key Takeaways

  • The majority of theophylline API originates from China and India.
  • Suppliers generally hold GMP and ISO certifications.
  • Prices range between $20 and $50 per kilogram depending on volume and quality standards.
  • Lead times average 8-12 weeks.
  • Regulatory filings can facilitate market access, especially for global markets.

FAQs

Q1: What are the main countries producing bulk theophylline API?
A: China, India, and select European contract manufacturers.

Q2: How does API quality certification affect sourcing?
A: GMP and ISO certifications ensure regulatory compliance and product consistency, critical for pharmaceutical approval.

Q3: Can I source theophylline API from companies with WHO prequalification?
A: Yes, suppliers with WHO prequalification have met international quality standards, easing access to multiple markets.

Q4: What is the typical lead time to receive bulk API?
A: 8 to 12 weeks, depending on supplier location and order size.

Q5: How are prices for bulk theophylline API determined?
A: By volume, certification, purity level, and contractual negotiations; prices typically range from $20 to $50 per kilogram.


References

[1] U.S. Food and Drug Administration. (2022). Drug Master Files. https://www.fda.gov/drugs/drug-registration-and-market-authorization/drug-master-files
[2] European Medicines Agency. (2023). Active Substance Master Files. https://www.ema.europa.eu/en/human-regulatory/research-development/quality-control/active-substance-master-files
[3] Global Trade Software. (2023). API Market Price Trends.
[4] Pharmaceuticals and Medical Devices Agency. (2022). API Regulatory Requirements in Japan.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.